Call us
+44 1204 543 529
Pharmaceuticals and Healthcare

PharmaSphere: Early-Stage Technology Transfer Collaborations - Enabling Platform Technologies & Deal Synergies between Academia and the Pharmaceutical Industry

Report code: GDHC003PSR
Published: Apr-2013
Formats:
  • Adobe PDF
Number of pages: 85
Description
Highlights
Key Benefits
Companies
Contents
Samples
  • The PharmaSphere: Early-Stage Technology Transfer Collaborations Report provides a cross-section of major licensing deals between mid to large-sized pharmaceutical companies and academic and nonprofit research institutions. This report examines the terms, platform technologies, and deal rationale of 25 pharma-academic alliances from 2012–2013. GlobalData’s Industry Dynamics team of analysts discusses the significant macro-environment drivers which are leading to an increase in research partnerships with academic research institutions on behalf of pharmaceutical companies. We also discuss the unsustainability of the current drug research model, and the industry’s attempts at moving toward an open R&D ecosystem.

    Scope

    Full examination of 25 significant technology transfer deals from 2012 and 2013 involving large pharmaceutical companies and academic organizations including licensing structure and terms

    Analysis of the key drivers, trends, and strategies behind the deals undertaken by these pharmaceutical companies across major therapeutic areas

    Discussion of the unsustainability of the current drug research model and how Big Pharma’s embrace of collaboration and an open ecosystem could drive the next wave of scientific discovery

    Tech Transfer in Action : Each section of the report includes a number of case studies and to highlight major themes within technology transfer

    Platform assessment on enabling drug technologies being employed by academic research institutions of interest to pharmaceutical companies

    Breakdown of disruptive innovation trends, including open-source patient data, pre-competitive information sharing, ‘Big Data’ and drug recycling/repurposing approaches

  • Request Sample Pages

  • ?
    Electronic PDF copy delivered via email.

    Report can be used by individual purchaser only.

    $2995
  • ?
    Electronic PDF copy delivered via email.

    Report can be shared by unlimited users within one corporate location,
    e.g. a regional office.

    $5990
  • ?
    Electronic PDF copy delivered via email.

    Report can be shared globally by unlimited users within the purchasing corporation
    e.g. all employees of a single company.

    $8985
Add to cart

Talk to us

Call us on +44 1204 543 529

Research Support

Get one-to-one support from our expert analysts only when you buy direct

Price Guarantee

You will not find our reports cheaper anywhere else

Customer Focused

Our client support team are on-hand to assist with your research needs

Unrivalled Expertise

700+ analysts delivering actionable insight